Stay current on pivotal oncology trials with practice-changing results, recruiting studies, and key readouts relevant to community cancer care.
Stay current on pivotal oncology trials with practice-changing results, recruiting studies, and key readouts relevant to community cancer care.
Pembrolizumab plus chemotherapy is changing first-line care for advanced endometrial cancer, with NRG GY018 showing major progression-free survival gains across MMR status.
